Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Statement Regarding the Prevention of Illegal Activities Under the Guise of "Health Element"
Time Posted：2024-12-26 13:20
At 8:40 am today, the group received a report that criminals were developing and operating the "Healthy Element" APP platform under the guise of the group, publishing and selling financial management products, and carrying out fraud. In response to this situation, the group makes the following solemn statement:
Time Posted：2024-12-05 14:35
Recently, we received notification from the National Pharmacopoeia Commission that the generic name application for Health Yuan's innovative influenza drug has been approved. It has been officially named "Mapaxisave" (the Chinese generic name for the raw material is "Mapaxisave", and the English name is "Pixavir Marboxil"; the Chinese generic name for the preparation is "Mapaxisave Capsules", and the English name is "Pixavir Marboxil Capsules").
ESG performance is eye-catching, and Health Yuan's MSCI rating has jumped to AA.
Time Posted：2023-10-31 14:11
Recently, MSCI, a leading international index provider, announced the results of its 2023 ESG (Environmental, Social, and Governance) rating for HealthGen. HealthGen's ESG rating was upgraded from "BBB" to "AA", a leading level in the industry. This upgrade reflects not only the recognition of HealthGen's ESG management achievements by the international capital market, but also its affirmation of its long-term sustainable development capabilities.
Time Posted：2023-03-30 18:23
What impact and disruption will ChatGPT have on the biopharmaceutical industry? Could the next innovative drug be AI-invented? Recently, following the global popularity of ChatGPT, various industries have begun to pay close attention to the power of technological transformation. The AI concept continues to empower various industries, and the pharmaceutical and medical fields are also being catalyzed by it. In fact, the application of AI in the pharmaceutical and medical fields has gradually transitioned from exploratory practice to commercial transformation. Many companies are already deploying in the AI pharmaceutical field. In the capital market, many institutions have suggested focusing on "AI + medical", "AI + pharmaceutical", and "AI +" opportunities. Hu'an Securities - Pharmaceutical and Biological Research Report points out that AI is a major annual theme, and it is recommended to participate throughout the year, especially companies with landing scenarios and revenue.
Time Posted：2025-05-09 14:28
Recently, to boost confidence in the capital market, Chinese regulators have rolled out a series of measures to encourage listed companies to actively return to investors through share buybacks and cash dividends. The China Securities Regulatory Commission (CSRC) has formulated guidelines for market value management and introduced policies encouraging dividends and buybacks, actively promoting a new era of A-share market value management.
AI Full-Chain Intelligent Upgrade: Health Yuan Starts Efficiency Innovation
Time Posted：2025-04-30 12:10
In the wave of intelligent transformation of the global pharmaceutical industry, artificial intelligence has become a core force driving the transformation of various industries. The pharmaceutical field is no exception, with AI reshaping the industrial landscape with unprecedented depth and breadth.
Health Spring: Resilience in Exchange for Elasticity
Time Posted：2025-04-16 13:15
It's time to test resilience! On one hand, there is downward pressure from the complex market, policy environment, and the transformation of the pharmaceutical industry; on the other hand, there is the upward opportunity of AI technology deeply empowering pharmaceutical companies to accelerate innovation. After a period of collective downturn, Chinese pharmaceutical companies are entering a stage of "structural" differentiation.
In 2024, how did Health Yuan answer the "three philosophical questions of life"?
Time Posted：2025-04-11 16:11
In 2024, how did Health Yuan answer the "three philosophical questions of corporate existence"? 2025-04-08 16:23 · Serious Finance Socrates' famous sayings, "Who am I?", "Where do I come from?", "Where am I going?", are three questions about life. For a company, especially a listed company, the questions of corporate existence cannot be avoided: "What kind of company is this?" "Where does the company's money come from?" "Where does the company's money go?"
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.